mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.07 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.07 |